{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:39:25Z","timestamp":1760146765923},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.transci.2008.05.006","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T11:29:46Z","timestamp":1215775786000},"page":"59-67","source":"Crossref","is-referenced-by-count":14,"title":["Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment"],"prefix":"10.1016","volume":"39","author":[{"given":"Tor-Einar","family":"Svae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Neisser-Svae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Biesert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Heger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"R\u00f6misch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.transci.2008.05.006_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1423-0410.1998.tb05410.x","article-title":"Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives","volume":"74","author":"Yap","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"264","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(98)24035-9","article-title":"Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease","volume":"352","author":"Hilton","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib8","first-page":"123","article-title":"The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects","volume":"81","author":"Smith","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.transci.2008.05.006_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(03)12632-3","article-title":"Deaths from variant Creutzfeldt-Jakob disease in the UK","volume":"361","author":"Andrews","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/adc.2003.048264","article-title":"American fresh frozen plasma for neonates and children","volume":"90","author":"Norfolk","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.transci.2008.05.006_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000073327","article-title":"Relevance of Creutzfeldt-Jakob disease and its variant for transfusion medicine","volume":"30","author":"Sachse","year":"2003","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2008.05.006_bib12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathies","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","article-title":"Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy","volume":"43","author":"Cervenakova","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1537-2995.2002.00098.x","article-title":"Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus","volume":"42","author":"Bons","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib15","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion","volume":"83","author":"Hunter","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.transci.2008.05.006_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-2141.1999.01530.x","article-title":"Preliminary assessment of whole-blood, red-cell and platelet-leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing","volume":"106","author":"Prowse","year":"1999","journal-title":"Br J Haematol"},{"issue":"Suppl. 2","key":"10.1016\/j.transci.2008.05.006_bib17","first-page":"24","article-title":"New-variant Creutzfeldt-Jakob disease and leukocyte depletion of blood components","volume":"26","author":"Williamson","year":"1999","journal-title":"Infus Ther Transfus Med"},{"key":"10.1016\/j.transci.2008.05.006_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(04)16812-8","article-title":"Effectiveness of leukoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood","volume":"364","author":"Gregori","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(01)05411-3","article-title":"Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues","volume":"358","author":"Bruce","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2008.05.006_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.0042-9007.2004.00411.x","article-title":"Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion","volume":"86","author":"Minor","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1423-0410.2005.00683.x","article-title":"Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy","volume":"89","author":"Brown","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib23","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1086\/319997","article-title":"Creutzfeldt-Jakob disease: recommendations for disinfection and sterilisation","volume":"32","author":"Rutala","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.transci.2008.05.006_bib24","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1741-6892.2004.00444.x","article-title":"Removal of TSE agents from blood products","volume":"87","author":"Foster","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib25","doi-asserted-by":"crossref","first-page":"11666","DOI":"10.1073\/pnas.1834432100","article-title":"A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions","volume":"100","author":"Klohn","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2008.05.006_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3148.1996.tb00071.x","article-title":"A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK","volume":"6","author":"Dealler","year":"1996","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2008.05.006_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","article-title":"Prevalence of lymphoreticular prion protein accumulation in UK tissue samples","volume":"203","author":"Hilton","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.transci.2008.05.006_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bmj.38804.511644.55","article-title":"Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study","volume":"332","author":"Ironside","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2008.05.006_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-0934(99)00135-4","article-title":"Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein","volume":"84","author":"Lee","year":"2000","journal-title":"J Virol Meth"},{"key":"10.1016\/j.transci.2008.05.006_bib30","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1046\/j.1537-2995.2002.00216.x","article-title":"Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma","volume":"42","author":"Stenland","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib31","unstructured":"EMEA\/CPMP\/BWP\/2879\/02\/rev 1. CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products. June 2004."},{"key":"10.1016\/j.transci.2008.05.006_bib32","unstructured":"CPMP\/ICH\/295\/95. Note for guidance on quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. March 1997."},{"key":"10.1016\/j.transci.2008.05.006_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1537-2995.1999.39111169.x","article-title":"Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans","volume":"39","author":"Brown","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib34","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1128\/JVI.79.14.8904-8908.2005","article-title":"High incidence of scrapie induced by repeated injections of subinfectious prion doses","volume":"79","author":"Jaquemot","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.transci.2008.05.006_bib35","doi-asserted-by":"crossref","unstructured":"British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. The Brit Soc Haematol 2004; 126:11\u201328.","DOI":"10.1111\/j.1365-2141.2004.04972.x"},{"key":"10.1016\/j.transci.2008.05.006_bib36","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1098\/rspb.2002.2156","article-title":"Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels","volume":"269","author":"Donnelly","year":"2002","journal-title":"Proc R Soc Lond B"},{"key":"10.1016\/j.transci.2008.05.006_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1191\/0962280203sm329ra","article-title":"Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis","volume":"12","author":"Boelle","year":"2003","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.transci.2008.05.006_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1423-0410.2000.7820086.x","article-title":"Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products","volume":"78","author":"Foster","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1537-2995.2001.41040449.x","article-title":"A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins","volume":"41","author":"Lee","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/biol.2002.0327","article-title":"Purity of spiking agent affects partitioning of prions in plasma protein purification","volume":"30","author":"Vey","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.transci.2008.05.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biologicals.2003.08.004","article-title":"Partitioning of TSE infectivity during ethanol fractionation of human plasma","volume":"32","author":"Gregori","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.transci.2008.05.006_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0042-9007.2004.00403.x","article-title":"Distribution of bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII","volume":"86","author":"Foster","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1423-0410.2006.00829.x","article-title":"Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins","volume":"91","author":"Thyer","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1423-0410.2002.00211.x","article-title":"Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin","volume":"83","author":"Reichl","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1423-0410.2003.00312.x","article-title":"Evaluation of depth filtration to remove prion challenge from an immune globulin preparation","volume":"85","author":"Van Holten","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2008.05.006_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5360\/membrane.18.357","article-title":"Removal of causative agent of Creutzfeldt-Jakob disease (CJD) through membrane filtration method","volume":"18","author":"Tateishi","year":"1993","journal-title":"Membrane"},{"key":"10.1016\/j.transci.2008.05.006_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1537-2995.2003.t01-1-00351.x","article-title":"Variant CJD transmission through blood: risks to predictors and \u201cpredictees\u201d","volume":"43","author":"Brown","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib48","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1537-2995.2006.00998.x","article-title":"Population-based audit of fresh-frozen plasma transfusion practices","volume":"46","author":"Palo","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2008.05.006_bib49","first-page":"517","article-title":"Blood clotting factors. Determination of activity and concentration of blood clotting factors in conventional and virus-inactivated coagulative plasma.","volume":"9","author":"Lutze","year":"1994","journal-title":"Krankenhauspharmazie"},{"key":"10.1016\/j.transci.2008.05.006_bib50","unstructured":"Guide to the preparation, use, and quality assurance of blood components. 9th ed. Strasbourg: Council of Europe Publishing; 2004."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050208000864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050208000864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T16:30:13Z","timestamp":1557678613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050208000864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1473050208000864"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2008.05.006","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}